拡張器：市場洞察・競合環境・市場予測 (～2030年)

世界の拡張器の市場規模は、2024年から2030年の予測期間中にCAGR 8.20％で成長すると予測されています。

骨盤臓器脱、尿路障害、胃腸障害などの慢性疾患では、症状を管理し患者のQOLを向上させるために外科的介入が必要となることが多いです。拡張器はこれらの処置に不可欠なツールです。さらに、最近の拡張器の技術的進歩は、その機能性、安全性、使いやすさを向上させることにより、市場を大幅に押し上げています。また、主要企業は革新的な拡張器を導入するための研究開発に継続的に投資しており、提携や協力の増加、製品の発売や承認により、2024年から2030年までの予測期間中、市場は引き続きダイナミックで革新的なものとなる見通しです。

拡張器市場の力学：

GLOBOCANが提供したデータによると、2022年に世界で新たに発生した食道がんの推定症例数は51万1,000例で、2045年までに85万2,000例に増加すると予測されています。さらに、同データによれば、2022年の膀胱がんの推定新規症例数は61万4,000人で、2045年までに112万人増加すると予測されています。食道がんは食道狭窄や食道の狭窄を引き起こし、嚥下を困難にする可能性があります。食道狭窄の治療には拡張器が使用され、狭くなった部分を徐々に広げ、患者の飲食能力を向上させます。また、膀胱がんの治療では、尿道狭窄や膀胱頸部狭窄を引き起こしたり悪化させたりする外科的処置が行われることがあります。拡張器は、尿道や膀胱頸部の狭窄部を拡大することでこれらの合併症に対処するために使用されており、これらのことから、世界の拡張器市場全体を押し上げています。

また、拡張器の最近の技術的進歩は、その機能性、安全性、使いやすさを向上させることにより、市場を大幅に押し上げています。超薄型で柔軟性のある素材などの技術革新により、解剖学的構造を通してより良いナビゲーションが可能になり、周辺組織への外傷が減少し、患者の不快感が最小限に抑えられています。さらに、使い捨て拡張器の開発により、二次汚染や感染のリスクが減少し、医療環境における患者の安全性が重視されています。また、リアルタイムの超音波やX線透視などの高度な画像技術を統合することで、外科医は標的部位をより正確に視覚化することができ、手技結果の改善につながります。

当レポートでは、世界の拡張器の市場を調査し、市場概要、市場影響因子および市場機会の分析、法規制環境、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 拡張器市場：イントロダクション

第2章 拡張器市場：エグゼクティブサマリー

第3章 競合情勢

第4章 規制分析

• 米国
• 欧州
• 日本
• 中国

第5章 拡張器市場：主要要因分析

• 市場促進要因
  • 骨盤臓器脱、尿路障害、胃腸障害など、外科的介入を必要とする慢性疾患の発生率の上昇
  • 超薄型・軟性素材などの技術進歩の増加
  • 世界的な製品開発活動の増加
• 市場抑制要因・課題
  • 拡張器に関連する感染症や組織損傷のリスク
  • 製品承認に関する厳格な規制上の懸念
• 市場機会
  • 拡張器へのAIの統合

第6章 拡張器市場：ポーターのファイブフォース分析

第7章 拡張器市場：市場評価

• 製品タイプ別
  • 婦人科用拡張器
  • 尿道拡張器
  • 食道拡張器
  • 虹彩拡張器
  • その他
• タイプ別
  • 機械
  • バルーン
• 用途別
  • 診断
  • 治療
• エンドユーザー別
  • 病院・クリニック
  • ヘルスケアセンター
• 地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 拡張器市場：企業・製品プロファイル

• Johnson and Johnson (Acclarent, Inc.)
• Hebson
• CONMED Corporation
• Scanlan International
• Medtronic
• Coloplast (Atos Medical AB)
• Teleflex Incorporated
• Medpro Medical B.V.
• Boston Scientific Corporation
• Soul Source Therapeutic Devices, Inc.
• Cook
• Olympus
• GPC Medical Ltd.
• Nidhi Meditech Systems
• CooperSurgical, Inc.
• Hologic, Inc
• MedGyn Products, Inc.
• Novo Surgical Inc.
• Medicem Group a.s.
• Panpac Medical Corp.

第9章 KOLの見解

第10章 プロジェクトアプローチ

第11章 DelveInsightについて

第12章 免責事項・お問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Dilators Market in Global (2021-2030)
• Table 3: Dilators Market in Global by Product Type (2021-2030)
• Table 4: Dilators Market in Global by Type (2021-2030)
• Table 5: Dilators Market in Global by Application (2021-2030)
• Table 6: Dilators Market in Global by End-User (2021-2030)
• Table 7: Dilators Market in Global by Geography (2021-2030)
• Table 8: Dilators Market in North America (2021-2030)
• Table 9: Dilators Market in the United States (2021-2030)
• Table 10: Dilators Market in Canada (2021-2030)
• Table 11: Dilators Market in Mexico (2021-2030)
• Table 12: Dilators Market in Europe (2021-2030)
• Table 13: Dilators Market in France (2021-2030)
• Table 14: Dilators Market in Germany (2021-2030)
• Table 15: Dilators Market in United Kingdom (2021-2030)
• Table 16: Dilators Market in Italy (2021-2030)
• Table 17: Dilators Market in Spain (2021-2030)
• Table 18: Dilators Market in the Rest of Europe (2021-2030)
• Table 19: Dilators Market in Asia-Pacific (2021-2030)
• Table 20: Dilators Market in China (2021-2030)
• Table 21: Dilators Market in Japan (2021-2030)
• Table 22: Dilators Market in India (2021-2030)
• Table 23: Dilators Market in Australia (2021-2030)
• Table 24: Dilators Market in South Korea (2021-2030)
• Table 25: Dilators Market in Rest of Asia-Pacific (2021-2030)
• Table 26: Dilators Market in the Rest of the World (2021-2030)
• Table 27: Dilators Market in the Middle East (2021-2030)
• Table 28: Dilators Market in Africa (2021-2030)
• Table 29: Dilators Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Dilators Market in Global (2021-2030)
• Figure 3: Dilators Market in Global by Product Type (2021-2030)
• Figure 4: Dilators Market in Global by Type (2021-2030)
• Figure 5: Dilators Market in Global by Application (2021-2030)
• Figure 6: Dilators Market in Global by End-User (2021-2030)
• Figure 7: Dilators Market in Global by Geography (2021-2030)
• Figure 8: Dilators Market in North America (2021-2030)
• Figure 9: Dilators Market in the United States (2021-2030)
• Figure 10: Dilators Market in Canada (2021-2030)
• Figure 11: Dilators Market in Mexico (2021-2030)
• Figure 12: Dilators Market in Europe (2021-2030)
• Figure 13: Dilators Market in France (2021-2030)
• Figure 14: Dilators Market in Germany (2021-2030)
• Figure 15: Dilators Market in United Kingdom (2021-2030)
• Figure 16: Dilators Market in Italy (2021-2030)
• Figure 17: Dilators Market in Spain (2021-2030)
• Figure 18: Dilators Market in the Rest of Europe (2021-2030)
• Figure 19: Dilators Market in Asia-Pacific (2021-2030)
• Figure 20: Dilators Market in China (2021-2030)
• Figure 21: Dilators Market in Japan (2021-2030)
• Figure 22: Dilators Market in India (2021-2030)
• Figure 23: Dilators Market in Australia (2021-2030)
• Figure 24: Dilators Market in South Korea (2021-2030)
• Figure 25: Dilators Market in Rest of Asia-Pacific (2021-2030)
• Figure 26: Dilators Market in the Rest of the World (2021-2030)
• Figure 27: Dilators Market in the Middle East (2021-2030)
• Figure 28: Dilators Market in Africa (2021-2030)
• Figure 29: Dilators Market in South America (2021-2030)
• Figure 30: Market Drivers
• Figure 31: Market Barriers
• Figure 31: Market Opportunities
• Figure 32: PORTER'S Five Force Analysis

Dilators Market by Product Type (Gynecological Dilators, Urethral Dilators, Esophageal Dilators, Iris Dilators, and, Others), Type (Mechanical and Balloon), Application (Diagnostic and Treatment), End-User (Hospitals & Clinics, Healthcare Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the rising incidence of chronic conditions that require surgical intervention, such as pelvic organ prolapse, urinary tract disorders, and gastrointestinal issues, increase in technology advancement, and increase in product launches and approvals by key market players across the globe.

The global dilators market is expected to grow at CAGR of 8.20% during the forecast period from 2024 to 2030. Chronic conditions such as pelvic organ prolapse, urinary tract disorders, and gastrointestinal issues often require surgical intervention to manage symptoms and improve patient quality of life. Dilators are essential tools in these procedures, used to expand or open body passages to facilitate access and treatment. Moreover, recent technological advancements in dilators have significantly boosted the market by enhancing their functionality, safety, and ease of use. Furthermore, key market players continuously investing in research and development to introduce innovative dilators, increased partnerships and collaborations, product launches and approvals ensures that market remains dynamic and innovative, during the forecast period from 2024 to 2030.

Dilators Market Dynamics:

According, to the data provided by the GLOBOCAN, in 2022 globally, the estimated new cases of esophagus cancer was 511,000 and the projection were indicated to increase 852,000 by 2045. Additionally as per the same source, the estimated new cases of bladder cancer in 2022 was 614,000 and the projection were indicated to increase 1.12 million by 2045. Thus, esophagus cancer can lead to esophageal strictures or narrowing of the esophagus, which can make swallowing difficult. Dilators are used in the treatment of esophageal strictures to gradually widen the narrowed sections, improving the patient's ability to eat and drink. Additionally, bladder cancer treatment may involve surgical procedures that result in or exacerbate urethral strictures or bladder neck stenosis. Dilators are used to manage these complications by expanding narrowed areas of the urethra or bladder neck thereby boosting the overall market of dilators across the globe.

Additionally, the vaginal cancer often require gynecological surgeries. As per the latest data provided by International Agency of Cancer, in 2022, globally, the estimated new cases of vaginal cancer was 614,000 and the projections were indicated to increase 1.12 million by 2045. Treatment for vaginal cancer often involves surgery, radiation therapy, or both, which can lead to complications such as vaginal stenosis or narrowing. Dilators are essential for maintaining vaginal patency and elasticity post-treatment, helping to prevent or manage stenosis. They are used to support the healing process and maintain vaginal function, which is crucial for patients recovering from vaginal cancer treatments thereby escalating the market of dilators across the globe.

Furthermore, recent technological advancements in dilators have significantly boosted the market by enhancing their functionality, safety, and ease of use. Innovations such as ultra-thin, flexible materials allow for better navigation through anatomical structures, reducing trauma to surrounding tissues and minimizing patient discomfort. Additionally, the development of single-use dilators decreases the risk of cross-contamination and infection, aligning with the growing emphasis on patient safety in healthcare settings. Integration of advanced imaging techniques, such as real-time ultrasound or fluoroscopy, enables surgeons to visualize the target area more accurately, leading to improved procedural outcomes. For instance, in May 2021, Merit Medical Endotek announced the launch of the Elation5 Dilation Balloon, the first and only 5-stage balloon on the market. Elation5 was designed to incrementally dilate strictures in the gastrointestinal tract with the widest diameter range available on a single balloon catheter.

Thus, the factors mentioned above are likely to boost the market of dilators during the forecasted period.

However, the risk of infections and tissue damage associated with dilators and stringent regulatory concerns for product approval may hinder the future market of dilators.

Dilators Market Segment Analysis:

Dilators Market by Product Type (Gynecological Dilators, Urethral Dilators, Esophageal Dilators, Iris Dilators, and, Others), Type (Mechanical and Balloon), Application (Diagnostic and Treatment), End-User (Hospitals & Clinics, Healthcare Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the dilators market, urethral dilators are projected to hold a considerable market share in 2023. Urethral dilators are significantly boosting the overall market of dilators by addressing a critical need in the management of various urological conditions. These specialized tools are designed to gently and effectively widen the urethra, which is crucial for treating urethral strictures, stenosis, and other obstructive disorders of the urinary tract. Urethral dilators support a range of medical interventions, from diagnostic procedures to pre- and post-surgical treatments, by enabling improved access and reducing obstruction. Advances in dilator technology, such as the development of more precise and ergonomically designed devices, enhance their efficacy and ease of use, further driving market growth.

Additionally, the increasing product approval across the globe are further propelling the market of the segment. For instance, In July 2023, Urotronic, Inc. announced that it received FDA approval for its Optilume(R) BPH Catheter System. This minimally invasive therapy combines mechanical dilation with a double-lobe balloon and the localized delivery of paclitaxel to treat lower urinary tract symptoms (LUTS) from BPH.

Therefore, owing to the above-mentioned factors, the urethral dilators category is expected to generate considerable revenue thereby pushing the overall growth of the global dilators market during the forecast period.

North America is expected to dominate the overall dilators market:

Among all the regions, North America is expected to hold the largest share in the global dilators market in 2023. The dilators market in North America is witnessing growth due to several factors like increase in surgical procedure for various chronic diseases, increase adoption of minimally invasive surgeries, and presence of key market players involved in the market expansion of dilators market in North America, catering to the increasing demand for advanced treatments and technologies across the region.

According, to the recent data and stats provided by American Cancer Society (2024), in the United States, approximately 22,370 new cases of esophageal cancer were diagnosed, with 17,690 cases in men and 4,680 cases in women. Additionally, as per the same source there were 13,820 new cases of invasive cervical cancer in the United States.

Esophageal cancer often requires interventions that involve the use of dilators. For instance, after surgery or radiation therapy, patients may experience esophageal strictures or narrowing, which necessitates the use of esophageal dilators to maintain a patent esophagus and facilitate swallowing. Additionally, cervical cancer treatment, including surgery or radiation, can lead to vaginal stenosis or narrowing. Vaginal dilators are often used post-treatment to prevent or address this condition, helping to maintain vaginal elasticity and function thus, thereby boosting the overall market of dilators across the region.

Furthermore, recent merger, acquisitions, positive clinical trials, and product approvals among key market players in the region further propels the market across the region. For example, In June 2024, Materna Medical, Inc., a leader in women's pelvic health solutions, announced the launch of a new clinical study called Prospective On Market Patient-reported Outcomes for Milli(TM) Vaginal Dilator (POMPOM). This important study aimed to collect data on how well the Milli Vaginal Dilator worked to relieve symptoms of veganism's and painful intercourse.

Therefore, the factors mentioned above are expected to boost the growth of the dilators market in the North American region during the forecast period from 2024 to 2030.

Dilators Market Key Players:

Some of the key market players operating in the dilators market include Johnson and Johnson (Acclarent, Inc.), Hebson, CONMED Corporation, Scanlan International, Medtronic, Coloplast (Atos Medical AB), Teleflex Incorporated, Medpro Medical B.V., Boston Scientific Corporation, Soul Source Therapeutic Devices, Inc., Cook, Olympus, GPC Medical Ltd., Nidhi Meditech Systems, CooperSurgical, Inc., Hologic, Inc., MedGyn Products, Inc., Novo Surgical Inc., Medicem Group a.s., Panpac Medical Corp., and others.

Recent Developmental Activities in the Dilators Market:

• In August 2023, Shanghai MicroPort Medical (Group) Co., Ltd. (MicroPort(R) Coronary) announced that its Firefighter(TM) NC Pro PTCA dilation Balloon Catheter received FDA market authorization. This new high-pressure balloon catheter aimed to enhance myocardial perfusion and was designed for dilating narrowed sections of coronary arteries or bypass grafts, as well as for post-stent dilation.

Key Takeaways From the Dilators Market Report Study:

• Market size analysis for current dilators size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the dilators market.
• Various opportunities available for the other competitors in the dilators market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current dilators market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for dilators market growth in the coming future?

Target Audience who can be Benefited From This Dilators Market Report Study:

• Dilators product providers
• Research organizations and consulting companies
• Dilators -related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in dilators
• Various end-users who want to know more about the dilators market and the latest technological developments in the dilators market.

Frequently Asked Questions for the Dilators Market:

1. What are dilators?

• A dilator is a surgical device that is used to induce an expansion of a passage or an opening inside the body.

2. What is the market for dilators?

• The global dilators market is expected to grow at CAGR of 8.20% during the forecast period from 2024 to 2030.

3. What are the drivers for the dilators market?

• Chronic conditions such as pelvic organ prolapse, urinary tract disorders, and gastrointestinal issues often require surgical intervention to manage symptoms and improve patient quality of life. Dilators are essential tools in these procedures, used to expand or open body passages to facilitate access and treatment. Moreover, recent technological advancements in dilators have significantly boosted the market by enhancing their functionality, safety, and ease of use. Furthermore, key market players continuously investing in research and development to introduce innovative dilators, increased partnerships and collaborations, product launches and approvals ensures that market remains dynamic and innovative, during the forecast period from 2024 to 2030.

4. Who are the key players operating in the dilators market?

• Some of the key market players operating in the Dilators market include Johnson and Johnson (Acclarent, Inc.), Hebson, CONMED Corporation, Scanlan International, Medtronic, Coloplast (Atos Medical AB), Teleflex Incorporated, Medpro Medical B.V., Boston Scientific Corporation, Soul Source Therapeutic Devices, Inc., Cook, Olympus, GPC Medical Ltd., Nidhi Meditech Systems, CooperSurgical, Inc., Hologic, Inc., MedGyn Products, Inc., Novo Surgical Inc., Medicem Group a.s., Panpac Medical Corp., and others.

5. Which region has the highest share in the dilators market?

• Among all the regions, North America is expected to hold the largest share in the global dilators market in 2023. The dilators market in North America is witnessing growth due to several factors like increase in surgical procedure for various chronic diseases, increase adoption of minimally invasive surgeries, and presence of key market players involved in the market expansion of dilators market in North America, catering to the increasing demand for advanced treatments and technologies across the region.

Table of Contents

1. Dilators Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Dilators Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Dilators Market Key Factors Analysis

• 5.1. Dilators Market Drivers
  • 5.1.1. Rising incidence of chronic conditions that require surgical intervention, such as pelvic organ prolapse, urinary tract disorders, and gastrointestinal issues
  • 5.1.2. Increase in technological advancement such as ultra-thin and flexible materials
  • 5.1.3. Increase in product development activities across the globe
• 5.2. Dilators Market Restraints and Challenges
  • 5.2.1. Risk of infections and tissue damage associated with dilators
  • 5.2.2. Stringent regulatory concerns for product approval
• 5.3. Dilators Market Opportunities
  • 5.3.1. The integration of artificial intelligence in dilators

6. Dilators Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Dilators Market Assessment

• 7.1. By Product Type
  • 7.1.1. Gynecological Dilators
  • 7.1.2. Urethral Dilators
  • 7.1.3. Esophageal Dilators
  • 7.1.4. Iris Dilators
  • 7.1.5. Others
• 7.2. By Type
  • 7.2.1. Mechanical
  • 7.2.2. Balloon
• 7.3. By Application
  • 7.3.1. Diagnostic
  • 7.3.2. Treatment
• 7.4. By End User
  • 7.4.1. Hospitals & Clinics
  • 7.4.2. Healthcare Centers
  • 7.4.3. Others
• 7.5. By Geography
  • 7.5.1. North America
    • 7.5.1.1. United States Dilators Market Size in USD Million (2021-2030)
    • 7.5.1.2. Canada Dilators Market Size in USD Million (2021-2030)
    • 7.5.1.3. Mexico Dilators Market Size in USD Million (2021-2030)
  • 7.5.2. Europe
    • 7.5.2.1. France Dilators Market Size in USD Million (2021-2030)
    • 7.5.2.2. Germany Dilators Market Size in USD Million (2021-2030)
    • 7.5.2.3. United Kingdom Dilators Market Size in USD Million (2021-2030)
    • 7.5.2.4. Italy Dilators Market Size in USD Million (2021-2030)
    • 7.5.2.5. Spain Dilators Market Size in USD Million (2021-2030)
    • 7.5.2.6. Rest of Europe Dilators Market Size in USD Million (2021-2030)
  • 7.5.3. Asia-Pacific
    • 7.5.3.1. China Dilators Market Size in USD Million (2021-2030)
    • 7.5.3.2. Japan Dilators Market Size in USD Million (2021-2030)
    • 7.5.3.3. India Dilators Market Size in USD Million (2021-2030)
    • 7.5.3.4. Australia Dilators Market Size in USD Million (2021-2030)
    • 7.5.3.5. South Korea Dilators Market Size in USD Million (2021-2030)
    • 7.5.3.6. Rest of Asia-Pacific Dilators Market Size in USD Million (2021-2030)
  • 7.5.4. Rest of the World (RoW)
    • 7.5.4.1. Middle East Dilators Market Size in USD Million (2021-2030)
    • 7.5.4.2. Africa Dilators Market Size in USD Million (2021-2030)
    • 7.5.4.3. South America Dilators Market Size in USD Million (2021-2030)

8. Dilators Market Company and Product Profiles

• 8.1. Johnson and Johnson (Acclarent, Inc.)
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Hebson
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. CONMED Corporation
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Scanlan International
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Medtronic
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Coloplast (Atos Medical AB)
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. Teleflex Incorporated
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. Medpro Medical B.V.
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Boston Scientific Corporation
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. Soul Source Therapeutic Devices, Inc.
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Cook
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Olympus
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. GPC Medical Ltd.
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. Nidhi Meditech Systems
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. CooperSurgical, Inc.
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy
• 8.16. Hologic, Inc
  • 8.16.1. Company Overview
  • 8.16.2. Company Snapshot
  • 8.16.3. Financial Overview
  • 8.16.4. Product Listing
  • 8.16.5. Entropy
• 8.17. MedGyn Products, Inc.
  • 8.17.1. Company Overview
  • 8.17.2. Company Snapshot
  • 8.17.3. Financial Overview
  • 8.17.4. Product Listing
  • 8.17.5. Entropy
• 8.18. Novo Surgical Inc.
  • 8.18.1. Company Overview
  • 8.18.2. Company Snapshot
  • 8.18.3. Financial Overview
  • 8.18.4. Product Listing
  • 8.18.5. Entropy
• 8.19. Medicem Group a.s.
  • 8.19.1. Company Overview
  • 8.19.2. Company Snapshot
  • 8.19.3. Financial Overview
  • 8.19.4. Product Listing
  • 8.19.5. Entropy
• 8.20. Panpac Medical Corp.
  • 8.20.1. Company Overview
  • 8.20.2. Company Snapshot
  • 8.20.3. Financial Overview
  • 8.20.4. Product Listing
  • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us